LncRNA MEG3-210 regulates endometrial stromal cells migration, invasion and apoptosis through p38 MAPK and PKA/SERCA2 signalling via interaction with Galectin-1 in endometriosis
Autor: | Yifei Lv, Jun Lin, Junyan Ma, Xiangwei Fei, Yang Liu, Ding Cui |
---|---|
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
Adult Stromal cell Galectin 1 Endometriosis 030209 endocrinology & metabolism Apoptosis Biology Peritoneal Diseases Biochemistry p38 Mitogen-Activated Protein Kinases Sarcoplasmic Reticulum Calcium-Transporting ATPases 03 medical and health sciences Endometrium 0302 clinical medicine Endocrinology Downregulation and upregulation Transcellular Cell Migration Cell Movement medicine Cell Adhesion Humans Protein kinase A Molecular Biology Cells Cultured MEG3 medicine.disease Cyclic AMP-Dependent Protein Kinases 030104 developmental biology Cancer cell Galectin-1 Cancer research Female RNA Long Noncoding Signal transduction Stromal Cells Protein Binding Signal Transduction |
Zdroj: | Molecular and cellular endocrinology. 513 |
ISSN: | 1872-8057 |
Popis: | Background Endometriosis is a benign gynaecological disease with malignant characteristics that severely affects women's quality of life. Long noncoding RNA maternally expressed gene 3 (LncRNA MEG3) is a tumour suppressor that is downregulated in various cancer cells and tissues, and regulates multiple biological processes. Emerging studies have revealed that the interactions between MEG3 and proteins are involved in disease progression. Galectin-1 affects cell motility, signal transduction and vascularization, and is overexpressed in endometriosis. Our study is the first to explore the role of MEG3-210 transcript in endometriosis and to reveal the regulatory mechanism mediated by the interaction between MEG3-210 and Galectin-1. Materials and methods Endometrial tissues and sera from patients with endometriosis and controls were collected. qRT–PCR was performed to detect the expression of MEG3-210 in the endometrium and endometrial stromal cells (ESCs). The CCK-8 assay, the Transwell assay, flow cytometry and animal models were conducted to evaluate the functions of MEG3-210 in vitro and in vivo. Bioinformatic analysis, Western blot assays, RNA-pull down assays and RNA immunoprecipitation were used to explore the potential mechanism of MEG3-210 in endometriosis. Results Our results showed that MEG3-210 expression was lower in the eutopic endometrium of women with endometriosis. MEG3-210 downregulation promoted ESCs migration, invasion, anti-apoptosis in vitro and growth of endometriotic lesions in vivo. Furthermore, MEG3-210 downregulation could activate p38 mitogen-activated protein kinase (p38 MAPK) and inhibit cAMP-dependent protein kinase A/sarcoplasmic reticulum Ca2+ ATPase 2 (PKA/SERCA2) signalling, which was mediated by Galectin-1. The protein levels of Galectin-1 in patients with endometriosis were elevated, and Galectin-1 siRNA could reduce the size of lesions. Conclusion MEG3-210 regulates ESCs through p38 MAPK and PKA/SERCA signalling via interaction with Galectin-1. The novel regulatory mechanism may provide new insights into drug therapy and the diagnosis of endometriosis. |
Databáze: | OpenAIRE |
Externí odkaz: |